Healthcare & Life Sciences
Umoja Biopharma
United Statesumoja-biopharma.com
Umoja Biopharma is a Healthcare & Life Sciences startup based in the United States, most recent round Series C+, 1 tracked investor.
Activeseries-c-plus
series-c-plus
Stage
1
Investors
About Umoja Biopharma
Umoja Biopharma is a company headquartered in the United States. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Umoja Biopharma develops in vivo CAR T cell therapies for cancer treatment using its proprietary VivoVec platform, which generates CAR T cells directly within patients to simplify and accelerate therapy delivery.
Explore Umoja Biopharma's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.